カテゴリー： Market Monitor Global, 世界, 医療/バイオ

自己細胞療法製品のグローバル市場展望 2023年-2029年：自家幹細胞移植、自家T細胞療法、多血小板血漿（PRP）療法、その他

◆英語タイトル：Autologous Cell Therapy Products Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14235）

◆商品コード：MMG23DC14235
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の自己細胞療法製品市場規模と予測を収録しています。・世界の自己細胞療法製品市場：売上、2018年-2023年、2024年-2029年
・世界の自己細胞療法製品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の自己細胞療法製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「自家幹細胞移植」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

自己細胞療法製品のグローバル主要企業は、Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 Johnson & Johnson、 Autolus Therapeutics、 FOSUNKite、 JW Therapeutics、 CARsgen Therapeutics、 Sorrento Therapeutics、 Mustang Bio、 Cellectis、 Allogene Therapeutics、 Celyad Oncology、 Bluebird Bio、 Lonzaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、自己細胞療法製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の自己細胞療法製品市場：タイプ別、2018年-2023年、2024年-2029年
世界の自己細胞療法製品市場：タイプ別市場シェア、2022年
・自家幹細胞移植、自家T細胞療法、多血小板血漿（PRP）療法、その他

世界の自己細胞療法製品市場：用途別、2018年-2023年、2024年-2029年
世界の自己細胞療法製品市場：用途別市場シェア、2022年
・癌、血友病、その他

世界の自己細胞療法製品市場：地域・国別、2018年-2023年、2024年-2029年
世界の自己細胞療法製品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における自己細胞療法製品のグローバル売上、2018年-2023年
・主要企業における自己細胞療法製品のグローバル売上シェア、2022年
・主要企業における自己細胞療法製品のグローバル販売量、2018年-2023年
・主要企業における自己細胞療法製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 Johnson & Johnson、 Autolus Therapeutics、 FOSUNKite、 JW Therapeutics、 CARsgen Therapeutics、 Sorrento Therapeutics、 Mustang Bio、 Cellectis、 Allogene Therapeutics、 Celyad Oncology、 Bluebird Bio、 Lonza

*************************************************************

・調査・分析レポートの概要
自己細胞療法製品市場の定義
市場セグメント
世界の自己細胞療法製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の自己細胞療法製品市場規模
世界の自己細胞療法製品市場規模：2022年 VS 2029年
世界の自己細胞療法製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの自己細胞療法製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の自己細胞療法製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：自家幹細胞移植、自家T細胞療法、多血小板血漿（PRP）療法、その他
自己細胞療法製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：癌、血友病、その他
自己細胞療法製品の用途別グローバル売上・予測

・地域別市場分析
地域別自己細胞療法製品市場規模 2022年と2029年
地域別自己細胞療法製品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 Johnson & Johnson、 Autolus Therapeutics、 FOSUNKite、 JW Therapeutics、 CARsgen Therapeutics、 Sorrento Therapeutics、 Mustang Bio、 Cellectis、 Allogene Therapeutics、 Celyad Oncology、 Bluebird Bio、 Lonza
...

This research report provides a comprehensive analysis of the Autologous Cell Therapy Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Autologous Cell Therapy Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Autologous Cell Therapy Products, challenges faced by the industry, and potential opportunities for market players.
The global Autologous Cell Therapy Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Autologous Cell Therapy Products market presents opportunities for various stakeholders, including Cancer, Hemophilia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Autologous Cell Therapy Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Autologous Cell Therapy Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Autologous Cell Therapy Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Autologous Cell Therapy Products market.
Market Overview: The report provides a comprehensive overview of the Autologous Cell Therapy Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Autologous Stem Cell Transplants, Autologous T Cell Therapies), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Autologous Cell Therapy Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Autologous Cell Therapy Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Autologous Cell Therapy Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Autologous Cell Therapy Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Autologous Cell Therapy Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Autologous Cell Therapy Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Autologous Cell Therapy Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Autologous Cell Therapy Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Autologous Cell Therapy Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Autologous Stem Cell Transplants
Autologous T Cell Therapies
Platelet-Rich Plasma (PRP) Therapy
Others
Market segment by Application
Cancer
Hemophilia
Others
Global Autologous Cell Therapy Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Gilead Sciences
Bristol-Myers Squibb
Johnson & Johnson
Autolus Therapeutics
FOSUNKite
JW Therapeutics
CARsgen Therapeutics
Sorrento Therapeutics
Mustang Bio
Cellectis
Allogene Therapeutics
Celyad Oncology
Bluebird Bio
Lonza
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Cell Therapy Products, market overview.
Chapter 2: Global Autologous Cell Therapy Products market size in revenue and volume.
Chapter 3: Detailed analysis of Autologous Cell Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Cell Therapy Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Autologous Cell Therapy Products capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Autologous Cell Therapy Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Cell Therapy Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Cell Therapy Products Overall Market Size
2.1 Global Autologous Cell Therapy Products Market Size: 2022 VS 2029
2.2 Global Autologous Cell Therapy Products Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Autologous Cell Therapy Products Sales: 2018-2029
3 Company Landscape
3.1 Top Autologous Cell Therapy Products Players in Global Market
3.2 Top Global Autologous Cell Therapy Products Companies Ranked by Revenue
3.3 Global Autologous Cell Therapy Products Revenue by Companies
3.4 Global Autologous Cell Therapy Products Sales by Companies
3.5 Global Autologous Cell Therapy Products Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Autologous Cell Therapy Products Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Autologous Cell Therapy Products Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autologous Cell Therapy Products Players in Global Market
3.8.1 List of Global Tier 1 Autologous Cell Therapy Products Companies
3.8.2 List of Global Tier 2 and Tier 3 Autologous Cell Therapy Products Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Autologous Cell Therapy Products Market Size Markets, 2022 & 2029
4.1.2 Autologous Stem Cell Transplants
4.1.3 Autologous T Cell Therapies
4.1.4 Platelet-Rich Plasma (PRP) Therapy
4.1.5 Others
4.2 By Type – Global Autologous Cell Therapy Products Revenue & Forecasts
4.2.1 By Type – Global Autologous Cell Therapy Products Revenue, 2018-2023
4.2.2 By Type – Global Autologous Cell Therapy Products Revenue, 2024-2029
4.2.3 By Type – Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
4.3 By Type – Global Autologous Cell Therapy Products Sales & Forecasts
4.3.1 By Type – Global Autologous Cell Therapy Products Sales, 2018-2023
4.3.2 By Type – Global Autologous Cell Therapy Products Sales, 2024-2029
4.3.3 By Type – Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
4.4 By Type – Global Autologous Cell Therapy Products Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Autologous Cell Therapy Products Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Hemophilia
5.1.4 Others
5.2 By Application – Global Autologous Cell Therapy Products Revenue & Forecasts
5.2.1 By Application – Global Autologous Cell Therapy Products Revenue, 2018-2023
5.2.2 By Application – Global Autologous Cell Therapy Products Revenue, 2024-2029
5.2.3 By Application – Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
5.3 By Application – Global Autologous Cell Therapy Products Sales & Forecasts
5.3.1 By Application – Global Autologous Cell Therapy Products Sales, 2018-2023
5.3.2 By Application – Global Autologous Cell Therapy Products Sales, 2024-2029
5.3.3 By Application – Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
5.4 By Application – Global Autologous Cell Therapy Products Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Autologous Cell Therapy Products Market Size, 2022 & 2029
6.2 By Region – Global Autologous Cell Therapy Products Revenue & Forecasts
6.2.1 By Region – Global Autologous Cell Therapy Products Revenue, 2018-2023
6.2.2 By Region – Global Autologous Cell Therapy Products Revenue, 2024-2029
6.2.3 By Region – Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
6.3 By Region – Global Autologous Cell Therapy Products Sales & Forecasts
6.3.1 By Region – Global Autologous Cell Therapy Products Sales, 2018-2023
6.3.2 By Region – Global Autologous Cell Therapy Products Sales, 2024-2029
6.3.3 By Region – Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Autologous Cell Therapy Products Revenue, 2018-2029
6.4.2 By Country – North America Autologous Cell Therapy Products Sales, 2018-2029
6.4.3 US Autologous Cell Therapy Products Market Size, 2018-2029
6.4.4 Canada Autologous Cell Therapy Products Market Size, 2018-2029
6.4.5 Mexico Autologous Cell Therapy Products Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Autologous Cell Therapy Products Revenue, 2018-2029
6.5.2 By Country – Europe Autologous Cell Therapy Products Sales, 2018-2029
6.5.3 Germany Autologous Cell Therapy Products Market Size, 2018-2029
6.5.4 France Autologous Cell Therapy Products Market Size, 2018-2029
6.5.5 U.K. Autologous Cell Therapy Products Market Size, 2018-2029
6.5.6 Italy Autologous Cell Therapy Products Market Size, 2018-2029
6.5.7 Russia Autologous Cell Therapy Products Market Size, 2018-2029
6.5.8 Nordic Countries Autologous Cell Therapy Products Market Size, 2018-2029
6.5.9 Benelux Autologous Cell Therapy Products Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Autologous Cell Therapy Products Revenue, 2018-2029
6.6.2 By Region – Asia Autologous Cell Therapy Products Sales, 2018-2029
6.6.3 China Autologous Cell Therapy Products Market Size, 2018-2029
6.6.4 Japan Autologous Cell Therapy Products Market Size, 2018-2029
6.6.5 South Korea Autologous Cell Therapy Products Market Size, 2018-2029
6.6.6 Southeast Asia Autologous Cell Therapy Products Market Size, 2018-2029
6.6.7 India Autologous Cell Therapy Products Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Autologous Cell Therapy Products Revenue, 2018-2029
6.7.2 By Country – South America Autologous Cell Therapy Products Sales, 2018-2029
6.7.3 Brazil Autologous Cell Therapy Products Market Size, 2018-2029
6.7.4 Argentina Autologous Cell Therapy Products Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Autologous Cell Therapy Products Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Autologous Cell Therapy Products Sales, 2018-2029
6.8.3 Turkey Autologous Cell Therapy Products Market Size, 2018-2029
6.8.4 Israel Autologous Cell Therapy Products Market Size, 2018-2029
6.8.5 Saudi Arabia Autologous Cell Therapy Products Market Size, 2018-2029
6.8.6 UAE Autologous Cell Therapy Products Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Autologous Cell Therapy Products Major Product Offerings
7.1.4 Novartis Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Autologous Cell Therapy Products Major Product Offerings
7.2.4 Gilead Sciences Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Major Product Offerings
7.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Autologous Cell Therapy Products Major Product Offerings
7.4.4 Johnson & Johnson Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Autolus Therapeutics
7.5.1 Autolus Therapeutics Company Summary
7.5.2 Autolus Therapeutics Business Overview
7.5.3 Autolus Therapeutics Autologous Cell Therapy Products Major Product Offerings
7.5.4 Autolus Therapeutics Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.5.5 Autolus Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Autologous Cell Therapy Products Major Product Offerings
7.6.4 FOSUNKite Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 JW Therapeutics
7.7.1 JW Therapeutics Company Summary
7.7.2 JW Therapeutics Business Overview
7.7.3 JW Therapeutics Autologous Cell Therapy Products Major Product Offerings
7.7.4 JW Therapeutics Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.7.5 JW Therapeutics Key News & Latest Developments
7.8 CARsgen Therapeutics
7.8.1 CARsgen Therapeutics Company Summary
7.8.2 CARsgen Therapeutics Business Overview
7.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Major Product Offerings
7.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.8.5 CARsgen Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Major Product Offerings
7.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Company Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio Autologous Cell Therapy Products Major Product Offerings
7.10.4 Mustang Bio Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Cellectis
7.11.1 Cellectis Company Summary
7.11.2 Cellectis Business Overview
7.11.3 Cellectis Autologous Cell Therapy Products Major Product Offerings
7.11.4 Cellectis Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.11.5 Cellectis Key News & Latest Developments
7.12 Allogene Therapeutics
7.12.1 Allogene Therapeutics Company Summary
7.12.2 Allogene Therapeutics Business Overview
7.12.3 Allogene Therapeutics Autologous Cell Therapy Products Major Product Offerings
7.12.4 Allogene Therapeutics Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.12.5 Allogene Therapeutics Key News & Latest Developments
7.13 Celyad Oncology
7.13.1 Celyad Oncology Company Summary
7.13.2 Celyad Oncology Business Overview
7.13.3 Celyad Oncology Autologous Cell Therapy Products Major Product Offerings
7.13.4 Celyad Oncology Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.13.5 Celyad Oncology Key News & Latest Developments
7.14 Bluebird Bio
7.14.1 Bluebird Bio Company Summary
7.14.2 Bluebird Bio Business Overview
7.14.3 Bluebird Bio Autologous Cell Therapy Products Major Product Offerings
7.14.4 Bluebird Bio Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.14.5 Bluebird Bio Key News & Latest Developments
7.15 Lonza
7.15.1 Lonza Company Summary
7.15.2 Lonza Business Overview
7.15.3 Lonza Autologous Cell Therapy Products Major Product Offerings
7.15.4 Lonza Autologous Cell Therapy Products Sales and Revenue in Global (2018-2023)
7.15.5 Lonza Key News & Latest Developments
8 Global Autologous Cell Therapy Products Production Capacity, Analysis
8.1 Global Autologous Cell Therapy Products Production Capacity, 2018-2029
8.2 Autologous Cell Therapy Products Production Capacity of Key Manufacturers in Global Market
8.3 Global Autologous Cell Therapy Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autologous Cell Therapy Products Supply Chain Analysis
10.1 Autologous Cell Therapy Products Industry Value Chain
10.2 Autologous Cell Therapy Products Upstream Market
10.3 Autologous Cell Therapy Products Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autologous Cell Therapy Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Autologous Cell Therapy Products in Global Market
Table 2. Top Autologous Cell Therapy Products Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Autologous Cell Therapy Products Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Autologous Cell Therapy Products Revenue Share by Companies, 2018-2023
Table 5. Global Autologous Cell Therapy Products Sales by Companies, (K Units), 2018-2023
Table 6. Global Autologous Cell Therapy Products Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Autologous Cell Therapy Products Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Autologous Cell Therapy Products Product Type
Table 9. List of Global Tier 1 Autologous Cell Therapy Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Cell Therapy Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Autologous Cell Therapy Products Sales (K Units), 2018-2023
Table 15. By Type - Global Autologous Cell Therapy Products Sales (K Units), 2024-2029
Table 16. By Application – Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Autologous Cell Therapy Products Sales (K Units), 2018-2023
Table 20. By Application - Global Autologous Cell Therapy Products Sales (K Units), 2024-2029
Table 21. By Region – Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Autologous Cell Therapy Products Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Autologous Cell Therapy Products Sales (K Units), 2018-2023
Table 25. By Region - Global Autologous Cell Therapy Products Sales (K Units), 2024-2029
Table 26. By Country - North America Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Autologous Cell Therapy Products Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Autologous Cell Therapy Products Sales, (K Units), 2018-2023
Table 29. By Country - North America Autologous Cell Therapy Products Sales, (K Units), 2024-2029
Table 30. By Country - Europe Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Autologous Cell Therapy Products Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Autologous Cell Therapy Products Sales, (K Units), 2018-2023
Table 33. By Country - Europe Autologous Cell Therapy Products Sales, (K Units), 2024-2029
Table 34. By Region - Asia Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Autologous Cell Therapy Products Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Autologous Cell Therapy Products Sales, (K Units), 2018-2023
Table 37. By Region - Asia Autologous Cell Therapy Products Sales, (K Units), 2024-2029
Table 38. By Country - South America Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Autologous Cell Therapy Products Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Autologous Cell Therapy Products Sales, (K Units), 2018-2023
Table 41. By Country - South America Autologous Cell Therapy Products Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Autologous Cell Therapy Products Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Autologous Cell Therapy Products Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Autologous Cell Therapy Products Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Autologous Cell Therapy Products Product Offerings
Table 48. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Autologous Cell Therapy Products Product Offerings
Table 52. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Autologous Cell Therapy Products Product Offerings
Table 56. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Autologous Cell Therapy Products Product Offerings
Table 60. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Autolus Therapeutics Company Summary
Table 63. Autolus Therapeutics Autologous Cell Therapy Products Product Offerings
Table 64. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Autolus Therapeutics Key News & Latest Developments
Table 66. FOSUNKite Company Summary
Table 67. FOSUNKite Autologous Cell Therapy Products Product Offerings
Table 68. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. FOSUNKite Key News & Latest Developments
Table 70. JW Therapeutics Company Summary
Table 71. JW Therapeutics Autologous Cell Therapy Products Product Offerings
Table 72. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. JW Therapeutics Key News & Latest Developments
Table 74. CARsgen Therapeutics Company Summary
Table 75. CARsgen Therapeutics Autologous Cell Therapy Products Product Offerings
Table 76. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. CARsgen Therapeutics Key News & Latest Developments
Table 78. Sorrento Therapeutics Company Summary
Table 79. Sorrento Therapeutics Autologous Cell Therapy Products Product Offerings
Table 80. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Sorrento Therapeutics Key News & Latest Developments
Table 82. Mustang Bio Company Summary
Table 83. Mustang Bio Autologous Cell Therapy Products Product Offerings
Table 84. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Mustang Bio Key News & Latest Developments
Table 86. Cellectis Company Summary
Table 87. Cellectis Autologous Cell Therapy Products Product Offerings
Table 88. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Cellectis Key News & Latest Developments
Table 90. Allogene Therapeutics Company Summary
Table 91. Allogene Therapeutics Autologous Cell Therapy Products Product Offerings
Table 92. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Allogene Therapeutics Key News & Latest Developments
Table 94. Celyad Oncology Company Summary
Table 95. Celyad Oncology Autologous Cell Therapy Products Product Offerings
Table 96. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Celyad Oncology Key News & Latest Developments
Table 98. Bluebird Bio Company Summary
Table 99. Bluebird Bio Autologous Cell Therapy Products Product Offerings
Table 100. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Bluebird Bio Key News & Latest Developments
Table 102. Lonza Company Summary
Table 103. Lonza Autologous Cell Therapy Products Product Offerings
Table 104. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Lonza Key News & Latest Developments
Table 106. Autologous Cell Therapy Products Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Autologous Cell Therapy Products Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Autologous Cell Therapy Products Production by Region, 2018-2023 (K Units)
Table 109. Global Autologous Cell Therapy Products Production by Region, 2024-2029 (K Units)
Table 110. Autologous Cell Therapy Products Market Opportunities & Trends in Global Market
Table 111. Autologous Cell Therapy Products Market Drivers in Global Market
Table 112. Autologous Cell Therapy Products Market Restraints in Global Market
Table 113. Autologous Cell Therapy Products Raw Materials
Table 114. Autologous Cell Therapy Products Raw Materials Suppliers in Global Market
Table 115. Typical Autologous Cell Therapy Products Downstream
Table 116. Autologous Cell Therapy Products Downstream Clients in Global Market
Table 117. Autologous Cell Therapy Products Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Autologous Cell Therapy Products Segment by Type in 2022
Figure 2. Autologous Cell Therapy Products Segment by Application in 2022
Figure 3. Global Autologous Cell Therapy Products Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autologous Cell Therapy Products Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Autologous Cell Therapy Products Revenue, 2018-2029 (US$, Mn)
Figure 7. Autologous Cell Therapy Products Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Autologous Cell Therapy Products Revenue in 2022
Figure 9. By Type - Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 11. By Type - Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 12. By Type - Global Autologous Cell Therapy Products Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 15. By Application - Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 16. By Application - Global Autologous Cell Therapy Products Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Autologous Cell Therapy Products Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Autologous Cell Therapy Products Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 20. By Region - Global Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 21. By Country - North America Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 22. By Country - North America Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 23. US Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 28. Germany Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 29. France Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 37. China Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 41. India Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 43. By Country - South America Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 44. Brazil Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Autologous Cell Therapy Products Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Autologous Cell Therapy Products Sales Market Share, 2018-2029
Figure 48. Turkey Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Autologous Cell Therapy Products Revenue, (US$, Mn), 2018-2029
Figure 52. Global Autologous Cell Therapy Products Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Autologous Cell Therapy Products by Region, 2022 VS 2029
Figure 54. Autologous Cell Therapy Products Industry Value Chain
Figure 55. Marketing Channels

※参考情報

自己細胞療法製品は、患者自身の細胞を使用した治療法であり、再生医療や免疫療法の一環として注目されています。自己細胞療法の概念は、患者の体内から細胞を取り出し、それを培養したり加工したりしてから再び患者に戻すというプロセスに基づいています。このアプローチにより、拒絶反応のリスクが低く、より効果的な治療が期待できるという特徴があります。

まず、自己細胞療法の基本的な定義を考えてみましょう。この療法は、主に患者自身の幹細胞、免疫細胞、その他の種類の細胞を用いて行われます。例えば、患者の骨髄から採取された幹細胞や末梢血からの免疫細胞が使用されることが一般的です。自己細胞療法は、特に再生医療や癌治療において、その有効性が注目されています。

自己細胞療法の特徴として、まず第一に、拒絶反応のリスクが抑えられる点があります。患者自身の細胞を使用するため、他人からの細胞移植に伴う免疫システムの反応が発生しにくいのです。また、この療法は個別化医療の一環でもあり、患者ごとに異なる治療法が提案される可能性があります。さらに、自己細胞を用いることで、長期的な治療効果が期待できる場合もあります。

自己細胞療法の種類には、幹細胞療法、T細胞療法、そして樹状細胞療法などがあります。幹細胞療法は、幹細胞を患者の体内に戻して、損傷した組織の再生を促進する目的で使用されます。特に、神経系や心臓、骨、軟骨などの再生を目指す研究が盛んに行われています。次に、T細胞療法は、免疫細胞の一種であるT細胞を用いた治療法で、特に癌治療においてその有効性が報告されています。患者のT細胞を取り出して培養し、癌細胞に対する攻撃力を高めた後、再び患者に戻すことが行われます。これにより、癌細胞を特異的に攻撃する能力が強化されます。最後に、樹状細胞療法は、免疫系の調整に寄与する樹状細胞を用いて、癌に対する免疫応答を高めるアプローチです。

自己細胞療法の用途はさまざまですが、主に癌治療と再生医療の分野で広がりを見せています。癌治療においては、CAR-T細胞療法などが代表的な例です。これは、患者のT細胞に遺伝子を改変して癌細胞を攻撃する能力を向上させる技術です。一方、再生医療の分野では、心筋梗塞や脊髄損傷、関節炎などの治療において、幹細胞療法が活用されています。

自己細胞療法に関連する技術も多岐にわたります。まず、細胞培養技術は、自己細胞療法において不可欠な要素です。細胞を体外で適切に培養し、増殖させ、活性化させるための技術が必要です。また、遺伝子編集技術も重要です。CRISPR/Cas9やTALENなどの技術によって、細胞の遺伝子を改変し、特定の機能を持たせることが可能になります。さらに、バイオセンサー技術やナノテクノロジーも、自己細胞療法の進歩に寄与しています。これらの技術は、細胞の挙動や機能をリアルタイムでモニタリングすることを可能にし、治療の効果を高めるために役立てられています。

さらに、自己細胞療法における倫理的な問題も重要なテーマです。患者自身の細胞を用いるため、倫理的な観点からの問題は比較的少ないものの、細胞の取得方法や培養環境の整備、さらには治療の効果についてのエビデンスの収集などにおいて、倫理的配慮が求められます。また、新しい治療法の承認に際しては、慎重な臨床試験が求められ、患者の安全が最優先されるべきです。

現代の医療における自己細胞療法の位置づけはますます重要性を増しています。研究の進展とともに、より多くの疾患に対する支持が期待され、将来的にはより多様な治療法が確立されることでしょう。自己細胞療法は、その可能性に満ちた分野であり、今後ますます進展していくことが見込まれます。これにより、患者の生活の質や治療成績の向上が実現されることが期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 自己細胞療法製品のグローバル市場展望 2023年-2029年：自家幹細胞移植、自家T細胞療法、多血小板血漿（PRP）療法、その他(Autologous Cell Therapy Products Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

自己細胞療法製品のグローバル市場展望 2023年-2029年：自家幹細胞移植、自家T細胞療法、多血小板血漿（PRP）療法、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp